Featured Research

from universities, journals, and other organizations

NSAIDs No Better Than Other Over-the-Counter Drugs for Low Back Pain

Date:
January 24, 2008
Source:
Center For The Advancement of Health
Summary:
When low back pain strikes, many people turn to non-steroidal anti-inflammatory drugs (NSAIDs), like naproxen and ibuprofen, or their newer COX-2 inhibitor cousin Celebrex. However, these drugs work no better than old faithful acetaminophen (Tylenol), according to a new review of studies. Review data “support guidelines for the management of low back pain in primary care that recommend NSAIDs as a treatment option after paracetamol has been tried, since there are fewer side effects with paracetamol,” said lead reviewer. Paracetamol is the European version of Tylenol.

When low back pain strikes, many people turn to non-steroidal anti-inflammatory drugs (NSAIDs), like naproxen and ibuprofen, or their newer COX-2 inhibitor cousin Celebrex. However, these drugs work no better than old faithful acetaminophen (Tylenol), according to a new review of studies.

Related Articles


Review data “support guidelines for the management of low back pain in primary care that recommend NSAIDs as a treatment option after paracetamol has been tried, since there are fewer side effects with paracetamol,” said lead reviewer Pepijn Roelofs. Paracetamol is the European version of Tylenol.

The researchers examined 65 studies, covering more than 11,000 low back pain sufferers. They concluded that NSAIDs are “slightly effective” for short-term symptomatic relief, allowing a return to normal activity in patients with acute and chronic low back pain without sciatica.

The review appears in the latest issue of The Cochrane Library, a publication of The Cochrane Collaboration, an international organization that evaluates medical research. Systematic reviews draw evidence-based conclusions about medical practice after considering both the content and quality of existing medical trials on a topic.

The authors cautioned doctors that while NSAIDs are appropriate for short-term use, improvements are small and it is unclear whether they work better than simple analgesics or other drugs. No kind of NSAID jumped out as any more effective than others are, either, in the studies reviewed.

Moreover, the data showed that NSAIDs were not superior to acetaminophen.

“Currently, the long-term use of NSAIDs is controversial because of cardiovascular adverse effects in patients with cardiovascular risk factors, such as previous angina pectoris, heart failure and myocardial infarction,” said Roelofs, a doctoral student at the Erasmus University Medical Centre in Rotterdam.

The researchers also looked at studies on the narcotics and muscle relaxants, finding that NSAIDs did not bring more relief, but did have fewer side effects.

NSAIDs have both painkilling and inflammation-quelling properties, but they can cause stomach upset or even ulcers. COX-2 inhibitor class drugs can result in fewer stomach problems, but the makers of the COX-2 inhibitor Vioxx pulled the drug from the market in 2004 after several reports of cardiovascular problems related to its use.

The review found that NSAIDs had more side effects than placebos. However, COX-2 drugs had fewer gastric side effects than other NSAIDs.

The researchers looked at “non-specific” low back pain; that is, pain not resulting from arthritis or sciatica.

“There is conflicting evidence,” the researchers said, “that NSAIDs are more effective than simple analgesics and bed rest, and moderate evidence that NSAIDS are not more effective than other drugs, physiotherapy or spinal manipulation for low back pain.”

“It varies from individual to individual,” said Jon Levine, M.D., a professor of medicine at University of California San Francisco who was not affiliated with the review. “If one NSAID does not work, you can try another. This is often a very empirical situation. If it takes care of the pain, wouldn’t you take it?”

Pain relievers also come in combination or physicians prescribe more than one at a time, Levine said.

Reference:  Roelofs PDDM, et al. Non-steroidal anti-inflammatory drugs for low-back pain. Cochrane Database of Systematic Reviews 2008, Issue 1.


Story Source:

The above story is based on materials provided by Center For The Advancement of Health. The original article was written by Star Lawrence. Note: Materials may be edited for content and length.


Cite This Page:

Center For The Advancement of Health. "NSAIDs No Better Than Other Over-the-Counter Drugs for Low Back Pain." ScienceDaily. ScienceDaily, 24 January 2008. <www.sciencedaily.com/releases/2008/01/080122203145.htm>.
Center For The Advancement of Health. (2008, January 24). NSAIDs No Better Than Other Over-the-Counter Drugs for Low Back Pain. ScienceDaily. Retrieved March 5, 2015 from www.sciencedaily.com/releases/2008/01/080122203145.htm
Center For The Advancement of Health. "NSAIDs No Better Than Other Over-the-Counter Drugs for Low Back Pain." ScienceDaily. www.sciencedaily.com/releases/2008/01/080122203145.htm (accessed March 5, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Thursday, March 5, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Bupa Eyes India Healthcare Opportunities

Bupa Eyes India Healthcare Opportunities

Reuters - Business Video Online (Mar. 5, 2015) — Bupa is hoping to expand in India&apos;s fast-growing health insurance market, once a rule change on foreign investment is implemented. The British private healthcare group&apos;s CEO tells Grace Pascoe why it&apos;s so keen on the new opportunity. Video provided by Reuters
Powered by NewsLook.com
Doctor in Your Pocket Is Getting Smarter

Doctor in Your Pocket Is Getting Smarter

Reuters - Business Video Online (Mar. 5, 2015) — Mobile apps are turning smartphones into a personal doctors, with users able to measure heart rate, blood pressure and even blood sugar. But will it change our behaviour? Ivor Bennett reports from the Mobile World Congress in Barcelona. Video provided by Reuters
Powered by NewsLook.com
AbbVie Inks $21B Deal To Buy Cancer Drugmaker Pharmacyclics

AbbVie Inks $21B Deal To Buy Cancer Drugmaker Pharmacyclics

Newsy (Mar. 5, 2015) — AbbVie announced Wednesday it will buy cancer drugmaker Pharmacyclics in a $21 billion deal. Video provided by Newsy
Powered by NewsLook.com
Adults Only Get The Flu Twice A Decade, Researchers Say

Adults Only Get The Flu Twice A Decade, Researchers Say

Newsy (Mar. 4, 2015) — Researchers found adults only get the flu about once every five years. Scientists analyzed how a person&apos;s immunity builds up over time as well. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins